课题基金 / 基金详情

Development and Characterization of Desmoglein-3 Specific T cells from Japanese Patients with Pemphigus Vulgaris

Development and Characterization of Desmoglein-3 Specific T cells from Japanese Patients with Pemphigus Vulgaris
日本寻常型天疱疮患者 Desmoglein-3 特异性 T 细胞的发育和表征
批准号:
10670804
负责人:
SAKURAI Toshiharu
金额:
$2.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

SAKURAI Toshiharu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to investigate the response of T lymphocytes from Japanese patients with pemphigus vulgaris (PV) to Desmoglein 3, the autoantigen of PV, and to characterize the properties of Dsg 3-specific T cells.1. We performed high resolution HLA class II typing in 14 Japanese PV patients presented from Dr Amagai using the PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism) method. There was a significant association of either DRB 1*14 (14/14:100%), DQB1*0503 (12/14:85%), or DQB1*0301(9/12:64%), when compared with healthy individuals. 2. The 11 recombinant Dsg 3 fusion proteins (Dsg 3. 1-11) with Maltose Binding Protein (MBP) were prepared to encompass each 40 amino acids staggered by 15 residues, starting from the EC 1 of Dsg 33. Autoreactive T cell responses to Dsg 3 were investigated in 14 PV patients and 20 healthy controls by coculture of PBMC with the 11 recombinant Dsg 3 fusion proteins and the incorporation of [ィイD13ィエD1H]-thymidine. Primary in vitro T cell responses (SI=1.9-2.7) to Dsg 3.9 (residues 201-204) or Dsg 3.10 (residues 226-265) were observed in 11/14 PV patients and 7/14 healthy individuals expressing the PV-associated HLA-DRB1*14 and DQB1*05. In contrast, PBMC from 6 normal controls carrying HLA class II alleles other than DRB1*14 and DQB1*05 were not stimulated by recombinant Dsg 3 fusion proteins. These observations demonstrate that T cell response to Dsg 3 can be detected in PV patients and in healthy donors carrying major histocompatibility complex class II alleles identical or similar to those highly prevalent in PV. And that suggests EC2-3 region of the Dsg 3 molecule may contain epitopes that are recognized by Dsg 3-specific T cell. This study will allow us to further develop and characterize the Dsg 3-specific T cell clone in Japanese PV patients.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Amagai Masayuki: "Autoimmunity against desmosomal cadherins in pemphigus"J Dermatol Sci.. 20. 92-102 (1999)
Amagai Masayuki:“天疱疮中针对桥粒钙粘蛋白的自身免疫”J Dermatol Sci.. 20. 92-102 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Amagai Masayuki: "Usefulness of enzyme-linked immunosorbent assay (ELISA) using reconbinant desmogleins 1 and 3 for serodiagnisis of pemphigus"British Journal of Dermatology. 140. 351-357 (1999)
Amagai Masayuki:“使用重组桥粒芯糖蛋白 1 和 3 进行酶联免疫吸附测定 (ELISA) 对天疱疮血清学诊断的有用性”《英国皮肤病学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Amagai Masayuki: "The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile"J Am Acad Dermatol. 40. 167-170 (1999)
Amagai Masayuki:“天疱疮的临床表型是由抗桥粒芯糖蛋白自身抗体谱定义的”J Am Acad Dermatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Amagai Masayuki: "Autoimmunology against desmosomal cadherins in pemphigus"Journal of Dermatological Science. 20. 92-102 (1999)
Amagai Masayuki:“针对天疱疮桥粒钙粘蛋白的自身免疫学”皮肤病学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
11
    Molecular link between stress response and cancer and its clinical implication
    • 批准号:
      17K09396
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2017
    • 负责人:
      SAKURAI Toshiharu
    • 依托单位:
    Novel molecular target in colorectal cancer and inflammatory bowel disease
    • 批准号:
      26460979
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2014
    • 负责人:
      SAKURAI Toshiharu
    • 依托单位:
    Translational research focusing on the regulation of proteasome by Gankyrin
    • 批准号:
      23590998
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      SAKURAI Toshiharu
    • 依托单位:
    Elucidation of the resistance mechanisms of immunotherapy by the abnormal signal transduction in melanoma and development of methods to overcome it
    • 批准号:
      21591445
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      SAKURAI Toshiharu
    • 依托单位:
    海外基金